Abstract | BACKGROUND: METHODS: In formalin-fixed tissues, the expression level of GalNAc-T14 protein was evaluated by immunohistochemistry assay in breast tissues. Expression profiles were assessed in normal tissues, benign fibroadenomas and several types of carcinomas. RESULTS: Our results showed that GalNAc-T14 was heterogeneously expressed in breast carcinomas compared to non-malignant tissue. GalNAc-T14 expression was observed in 47/56 (83.9%) carcinoma samples, 7/48 (14.6%) non-malignant breast tissue samples. GalNAc-T14 expression level was associated with histological grade. For this enzyme a significant association with invasive ductal type, mucinous adenocarcinoma and ductal carcinoma in situ ( DCIS) type was found. CONCLUSION: Our results provide evidence that GalNAc-T14 may be a potential biomarker for breast cancer by immunohistochemistry. GalNAc-T14 expression level was associated with histological grade. GalNAc-T14 expression can provide new insights about breast cancer glycobiology.
|
Authors | Chen Wu, Xiaodan Guo, Weina Wang, Yun Wang, Yaojun Shan, Bo Zhang, Wenqian Song, Sisi Ma, Jianfeng Ge, Hao Deng, Mingsheng Zhu |
Journal | BMC cancer
(BMC Cancer)
Vol. 10
Pg. 123
(Apr 01 2010)
ISSN: 1471-2407 [Electronic] England |
PMID | 20356418
(Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers, Tumor
- N-Acetylgalactosaminyltransferases
- UDP-N-acetyl-D-galactosamine polypeptide N-acetylgalactosaminyltransferase 14, human
|
Topics |
- Adenocarcinoma, Mucinous
(enzymology, pathology)
- Adult
- Aged
- Biomarkers, Tumor
(analysis)
- Breast Neoplasms
(enzymology, pathology)
- Carcinoma, Ductal, Breast
(enzymology, pathology)
- Carcinoma, Intraductal, Noninfiltrating
(enzymology, pathology)
- Female
- Humans
- Immunohistochemistry
- Middle Aged
- N-Acetylgalactosaminyltransferases
(analysis)
- Neoplasm Staging
- Predictive Value of Tests
|